Sustained release formulation of carbamazepine
US6162466A · kind A · utility
21Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 1999 |
| Grant date | Dec 19, 2000 |
| Priority date | — |
| Expiry date | Apr 15, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication, preferably a sustained release formulation, and most preferably a sustained release formulation where the active ingredient is carbamazepine. The product consists of carbamazepine particles coated with a single hydrophobic layer and is in a disintegrating tablet form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.